Skip to main content

Julia Dawn Visgauss

Assistant Professor of Orthopaedic Surgery
Orthopaedic Surgery

Overview


I specialize in pelvic resection and reconstructive surgery.  I have a special interest in researching and understanding how people’s gait is affected by pelvic surgery, and how we can improve reconstructive techniques in order to optimally balance restoration of anatomy and function.

My translational research is focused on understanding what drives disease progression and treatment resistance in sarcoma.  Currently my focus is in chondrosarcoma, a subtype of bone sarcoma that produces cartilage, and has extremely limited treatment options beyond surgery.  My lab is working to uncover the cellular derangements and immune interactions that allow these cells to metastasize, and develop targeted systemic therapies to improve patient outcomes.

Current Duke Appointments & Affiliations


Assistant Professor of Orthopaedic Surgery · 2021 - Present Orthopaedic Surgery, Clinical Science Departments
Member of the Duke Cancer Institute · 2019 - Present Duke Cancer Institute, Institutes and Centers

Recent Scholarly Works


Age- and level-dependent glucose metabolism in the lumbar spine and preliminary associations with severe low back pain: A retrospective FDG PET imaging study.

Journal article Osteoarthritis Cartilage · July 2026 OBJECTIVE: Low back pain is the world's most prevalent disability and lumbar disc degeneration is implicated as a pain driver. The discs are large avascular tissues and consequently fluid transport from adjacent vertebrae is required to perfuse the disc ti ... Full text Link to item Cite

The Association Between Perioperative Denosumab and Local Recurrence After Surgical Management of Giant Cell Tumors: A Meta-Analysis.

Journal article J Bone Joint Surg Am · April 15, 2026 BACKGROUND: Several studies have assessed the impact of perioperative denosumab on local recurrence (LR) after surgical management of giant cell tumor (GCT), with conflicting results. This meta-analysis evaluates the association between LR in patients unde ... Full text Link to item Cite

Exploring Best Practices for Screening for Financial Toxicity in Patients With Sarcoma: A Single-Institution Study.

Journal article JCO Oncol Pract · April 9, 2026 PURPOSE: Approximately three quarters of patients with sarcoma report financial toxicity, defined as the psychosocial and economic burden of cancer care. The Comprehensive Score for Financial Toxicity (COST) is a screening questionnaire validated in patien ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Defining and targeting CIC::DUX4-dependent survival in fusion-positive sarcomas

FellowshipCollaborator · Awarded by National Institutes of Health · 2025 - 2028

Investigating drivers and therapeutic approaches for LCP1 overexpression in chondrosarcoma

ResearchPrincipal Investigator · Awarded by The Musculoskeletal Tumor Society · 2024 - 2026

Fresh Tissue Lab

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Onkos Surgical, Inc · 2025 - 2025

View All Grants

Education


Johns Hopkins University, School of Medicine · 2012 M.D.